Rezafungin vs caspofungin for the treatment of invasive candidiasis: A systematic review and meta-analysis
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Diagnostic microbiology and infectious disease
- Publicado em
- 5 jul 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Rezafungin vs caspofungin for the treatment of invasive candidiasis: A systematic review and meta-analysis
Mohammad Al Diab Al Azzawi, Wejdan Abdat, Arina Alhamed, Amjad Salman A Alhothali, Razan Shukr Alsheikh, Hind Mohammed Almajed, Sultan Ibrahim S Alhamdi, Norah Nasser A Alshahrani, Abdalla Osman Eltayeb
Descritores MeSH
- Antifungal Agents
- Echinocandins
- Candidiasis, Invasive
- Caspofungin
- Randomized Controlled Trials as Topic
- Humans
- Treatment Outcome
Veja também
Estudos relacionados
- Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double-Blind, Randomised, Phase 3 Trial (ReSTORE China)
- Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses
- Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials
- Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin